bosentan anhydrous has been researched along with Innate Inflammatory Response in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behr, J; Jungck, D; Knobloch, J; Koch, A; Konradi, J; Lin, Y; Stoelben, E; Strauch, J | 1 |
| Behr, J; Feldmann, M; Jungck, D; Knobloch, J; Koch, A; Stoelben, E; Wahl, C | 1 |
| Fontoura, D; Leite, S; Leite-Moreira, AF; Lourenço, AP; Mendes-Ferreira, P; Oliveira-Pinto, J; Tavares-Silva, M; Vasques-Nóvoa, F | 1 |
| Goraca, A; Kleniewska, P; Kolodziejczyk, M; Kowalczyk, A; Skibska, B | 1 |
| Alessandro, B; Andrea, O; Antonio, P; Claudio, L; Daniela, R; Elisa, T; Federico, C; Giacomo, M; Giuseppe, A; Giuseppe, P; Mariaelisa, R; Marzia, D; Ruggero, B | 1 |
| Görgülü, T; Guler, R; Kargi, E; Olgun, A; Torun, M | 1 |
| Dinger, B; Fidone, S; He, L; Liu, X; Stensaas, L | 1 |
| Cetinel, S; Deniz, M; Kurtel, H | 1 |
| Gillissen, A; Haag, S; Juergens, UR; Lamyel, F; Novak, N; Racké, K; Stöber, M; Uen, S; Vetter, H | 1 |
| Andersson, SE; Hemsén, A; Lundberg, JM | 1 |
| Diener, HC; Ferrari, MD; Gijsman, HJ; Jones, R; May, A; Wallnöfer, A | 1 |
| Breu, V; Dechend, R; Ganten, D; Genersch, E; Haller, H; Löffler, BM; Luft, FC; Mervaala, EM; Muller, DN; Park, JK; Schmidt, F; Schneider, W | 1 |
| Badiwala, MV; Dhillon, B; Fedak, PW; Li, RK; Li, SH; Mickle, DA; Verma, S; Weisel, RD | 1 |
1 review(s) available for bosentan anhydrous and Innate Inflammatory Response
| Article | Year |
|---|---|
The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis.
Topics: Animals; Bosentan; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Humans; Inflammation; Lipopolysaccharides; NF-kappa B; Oligopeptides; Peptides, Cyclic; Piperidines; Pyridines; Reactive Oxygen Species; Sepsis; Signal Transduction; Sulfonamides; Superoxides; Tetrazoles | 2015 |
1 trial(s) available for bosentan anhydrous and Innate Inflammatory Response
| Article | Year |
|---|---|
Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks.
Topics: Adult; Blood Flow Velocity; Bosentan; Cerebrovascular Circulation; Double-Blind Method; Dura Mater; Endothelins; Female; Humans; Inflammation; Male; Middle Aged; Sulfonamides; Treatment Failure | 1996 |
11 other study(ies) available for bosentan anhydrous and Innate Inflammatory Response
| Article | Year |
|---|---|
Inflammatory responses of airway smooth muscle cells and effects of endothelin receptor antagonism.
Topics: Airway Remodeling; Bosentan; Chemokines; Endothelin Receptor Antagonists; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypertension, Pulmonary; Inflammation; Matrix Metalloproteinase 13; Myocytes, Smooth Muscle; Oligonucleotide Array Sequence Analysis; Phenylpropionates; Pulmonary Disease, Chronic Obstructive; Pyridazines; Receptors, Endothelin; RNA Stability; RNA, Messenger; Sulfonamides; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2013 |
Endothelin receptor antagonists attenuate the inflammatory response of human pulmonary vascular smooth muscle cells to bacterial endotoxin.
Topics: Anti-Inflammatory Agents; Bosentan; Cells, Cultured; Cytokines; Endothelin B Receptor Antagonists; Endothelin Receptor Antagonists; Humans; Inflammation; Interleukin-8; Lipopolysaccharide Receptors; Lipopolysaccharides; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oligopeptides; Phenylpropionates; Piperidines; Pulmonary Artery; Pyridazines; RNA, Messenger; Salmonella; Sulfonamides | 2013 |
Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension.
Topics: Animals; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Heart Ventricles; Hypertension, Pulmonary; Inflammation; Male; Monocrotaline; Rats; Rats, Wistar; Sulfonamides | 2014 |
Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis.
Topics: Anti-Inflammatory Agents; Bosentan; CD4-Positive T-Lymphocytes; Endothelin Receptor Antagonists; Endothelin-1; Female; Fibroblasts; Fibrosis; Humans; Inflammation; Interferon-gamma; Male; Middle Aged; Monocytes; Receptors, Endothelin; Scleroderma, Systemic; Sulfonamides | 2015 |
Evaluation of the Effect of Bosentan-Mediated Endothelin Receptor Blockade on Flap Survival in Rats: An Experimental Study.
Topics: Animals; Bosentan; Endothelin Receptor Antagonists; Inflammation; Ischemia; Male; Neovascularization, Physiologic; Rats; Rats, Wistar; Re-Epithelialization; Sulfonamides; Surgical Flaps | 2016 |
Effect of endothelin receptor antagonist bosentan on chronic hypoxia-induced inflammation and chemoafferent neuron adaptation in rat carotid body.
Topics: Acid Sensing Ion Channels; Adaptation, Physiological; Animals; Antihypertensive Agents; Bosentan; Carotid Body; Cell Movement; Chemokine CCL2; Chemoreceptor Cells; Chronic Disease; Endothelin-1; Gene Expression; Hypoxia; Inflammation; Interleukin-1; Interleukin-1beta; Leukocyte Common Antigens; Macrophages; Rats; Receptor, Endothelin A; Sulfonamides; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2012 |
Blood flow alterations in TNBS-induced colitis: role of endothelin receptors.
Topics: Animals; Antihypertensive Agents; Azepines; Bosentan; Colitis; Inflammation; Male; Mesenteric Arteries; Mucous Membrane; Oligopeptides; Peroxidase; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Regional Blood Flow; Sulfonamides; Time Factors; Trinitrobenzenesulfonic Acid | 2004 |
Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: new evidence for beneficial anti-inflammatory potency of ETB-receptor antagonism.
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Arachidonic Acid; Bosentan; Cell Line; Cell Separation; Dinoprostone; Endothelin B Receptor Antagonists; Fibroblasts; Humans; In Vitro Techniques; Inflammation; Interleukin-1beta; Lipoxygenase Inhibitors; Monocytes; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Tumor Necrosis Factor-alpha | 2008 |
The effect of endothelin receptor blockade on the development of the Sephadex-induced inflammation in the rat lung.
Topics: Animals; Bosentan; Dextrans; Endothelin Receptor Antagonists; Inflammation; Lung; Lung Diseases; Male; Rats; Rats, Sprague-Dawley; Sulfonamides | 1996 |
Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Bosentan; Cardiomegaly; Fibronectins; Heart; Humans; Hydralazine; Immunohistochemistry; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Macrophages; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Renin; Sulfonamides; Thromboplastin; Transcription Factor AP-1; Vascular Cell Adhesion Molecule-1 | 2000 |
Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.
Topics: Antibodies; Arteriosclerosis; Biomarkers; Bosentan; C-Reactive Protein; Cell Adhesion Molecules; Cells, Cultured; Chemokine CCL2; Endothelin-1; Endothelium, Vascular; Humans; Inflammation; Interleukin-6; Lipoproteins, LDL; Macrophages; Models, Cardiovascular; Sulfonamides | 2002 |